Pura Vida Investments, LLC Axsome Therapeutics, Inc. Call Options Transaction History

Pura Vida Investments, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2020 Aug 14, 2020	SELL	$49.87 - $98.69 $498,700 - $986,900	-10,000 Closed	0 $0
Q1 2020 Feb 12, 2021	BUY	$41.2 - $101.31 $407,880 - $1 Million	9,900 Added 9900.0%	10,000 $588,000
Q1 2020 May 15, 2020	SELL	$41.2 - $101.31 $6.48 Million - $15.9 Million	-157,300 Reduced 99.94%	100 $4,000
Q1 2019 Feb 12, 2021	BUY	$2.63 - $16.34 $409,822 - $2.55 Million	155,826 Added 9900.0%	157,400 $2.24 Million
Q1 2019 May 14, 2019	SELL	$2.63 - $16.34 $190,480 - $1.18 Million	-72,426 Reduced 97.87%	1,574 $1.15 Million
Q4 2018 Feb 11, 2021	BUY	$2.0 - $4.15 $146,520 - $304,029	73,260 Added 9900.0%	74,000 $209,000
Q4 2018 Feb 14, 2019	BUY	$2.0 - $4.15 $1,480 - $3,071	740 New	740 $13,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.77B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.